Chief Executive Officer of Vivos Therapeutics, Inc. (NASDAQ:VVOS), Huntsman Ronald Kirk, buys 1,000 shares worth $7,267

According to Vivos Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 06:53 PM, company Chief Executive Officer, Huntsman Ronald Kirk disclosed buying 1,000 shares at a cost of $7.27. At the time of this transaction (Dec 23), this trade was worth $7,267 in total. As of Dec 23, Huntsman Ronald Kirk now owns 1,500 shares in total worth about $11,250.0.

For the last few recent trades made by Vivos Therapeutics, Inc. (NASDAQ:VVOS) Chief Executive Officer, Huntsman Ronald Kirk, we have the following information:

Posted by George Daniels on Thursday December 24 2020, 10:11 AM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0